NASDAQ: GLYC       Glycomimetics Inc
Last Price Today's Change   Day's Range   Trading Volume
4.77   +0.08 (1.71%)  4.69 - 4.84  52,584


Avg Volume (4 weeks):257,200
4 Weeks Range:4.64 - 6.09
4 Weeks Price Volatility (%):
52 Weeks Range:2.64 - 13.56
52 Weeks Price Volatility (%):
Average Price Target: 14.00
Price Target Upside/Downside: +9.23


No recent Headlines for this stock.

Business Background

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

  Be the first to like this.


2414  3178  330  3044 

Top 10 Active Counters
 CELG 108.24+0.11 
 NIO 4.765-0.405 
 FCEL 2.189-0.691 
 AVP 5.60-0.05 
 CHK 0.599+0.002 
 AABA 19.630.00 
 NTRP 1.42-0.03 
 VIAB 24.22+0.75 
 GE 11.425-0.235 
 GNPX 1.97+0.82 
Partners & Brokers